LitCovid-sentences

PMC:7276828 / 531-538 JSON TXT

Increased ACE2 Expression in the Bronchial Epithelium of COPD Patients who are Overweight Abstract Abstract Objective Mortality from coronavirus disease 2019 (COVID‐19) is increased in COPD patients. Furthermore, higher body mass index (BMI) is related to severe disease. SARS‐CoV‐2 utilises angiotensin converting enzyme 2 (ACE2) to gain cellular entry. Methods We have investigated whether ACE2 bronchial epithelial expression is increased in COPD patients who are overweight compared to those who are not by RNA sequencing. Results We observed increased ACE2 expression in COPD patients who are overweight (mean BMI 29 kg/m2) compared to those notoverweight (mean BMI 21 kg/m2) (p=0.004). Conclusion Increased ACE2 expression may cause increased SARS‐CoV‐2 infection of the respiratory tract. COPD patients who are overweight may be at greater risk of developing severe COVID‐19.

Document structure show

article-title	Increased ACE2 Expression in the Bronchial Epithelium of COPD Patients who are Overweight
abstract	Abstract Objective Mortality from coronavirus disease 2019 (COVID‐19) is increased in COPD patients. Furthermore, higher body mass index (BMI) is related to severe disease. SARS‐CoV‐2 utilises angiotensin converting enzyme 2 (ACE2) to gain cellular entry. Methods We have investigated whether ACE2 bronchial epithelial expression is increased in COPD patients who are overweight compared to those who are not by RNA sequencing. Results We observed increased ACE2 expression in COPD patients who are overweight (mean BMI 29 kg/m2) compared to those notoverweight (mean BMI 21 kg/m2) (p=0.004). Conclusion Increased ACE2 expression may cause increased SARS‐CoV‐2 infection of the respiratory tract. COPD patients who are overweight may be at greater risk of developing severe COVID‐19.
title	Abstract
sec	Objective Mortality from coronavirus disease 2019 (COVID‐19) is increased in COPD patients. Furthermore, higher body mass index (BMI) is related to severe disease. SARS‐CoV‐2 utilises angiotensin converting enzyme 2 (ACE2) to gain cellular entry.
title	Objective
p	Mortality from coronavirus disease 2019 (COVID‐19) is increased in COPD patients. Furthermore, higher body mass index (BMI) is related to severe disease. SARS‐CoV‐2 utilises angiotensin converting enzyme 2 (ACE2) to gain cellular entry.
sec	Methods We have investigated whether ACE2 bronchial epithelial expression is increased in COPD patients who are overweight compared to those who are not by RNA sequencing.
title	Methods
p	We have investigated whether ACE2 bronchial epithelial expression is increased in COPD patients who are overweight compared to those who are not by RNA sequencing.
sec	Results We observed increased ACE2 expression in COPD patients who are overweight (mean BMI 29 kg/m2) compared to those notoverweight (mean BMI 21 kg/m2) (p=0.004).
title	Results
p	We observed increased ACE2 expression in COPD patients who are overweight (mean BMI 29 kg/m2) compared to those notoverweight (mean BMI 21 kg/m2) (p=0.004).
sec	Conclusion Increased ACE2 expression may cause increased SARS‐CoV‐2 infection of the respiratory tract. COPD patients who are overweight may be at greater risk of developing severe COVID‐19.
title	Conclusion
p	Increased ACE2 expression may cause increased SARS‐CoV‐2 infection of the respiratory tract. COPD patients who are overweight may be at greater risk of developing severe COVID‐19.

Annnotations TAB TSV DIC JSON TextAE

last updated at 2021-10-18 15:26:04 UTC

Denotations: 1
Blocks: 0
Relations: 0

PMC:7276828 / 531-538 JSONTXT

Document structure show

Annnotations TAB TSV DIC JSON TextAE

PMC:7276828 / 531-538 JSON TXT